Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Alniditan

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Alniditan
Clinical data
ATC code
  • none
Identifiers
  • N-[(2R)-3,4-dihydro-2H-chromen-2-ylmethyl]-N'-(1,4,5,6-tetrahydropyrimidin-2-yl)propane-1,3-diamine
CAS Number
PubChemCID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC17H26N4O
Molar mass302.422 g·mol−1
3D model (JSmol)
  • C1CNC(=NC1)NCCCNCC2CCC3=CC=CC=C3O2
  • InChI=1S/C17H26N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,5-6,15,18H,3-4,7-13H2,(H2,19,20,21)/t15-/m1/s1 checkY
  • Key:QVSXOXCYXPQXMF-OAHLLOKOSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Alniditan is a5-HT1D receptoragonist withmigraine-preventive effects.[1]

Synthesis

[edit]

The sizeable number of serotonergic drugs for treating migraines all incorporate the indole nucleus found in serotonin itself. It is thus of interest that a compound based on abenzopyran manifests much the same activity.

Alniditan synthesis:[2]

Alkylation ofphenol with 2-bromobutyrolactone (2) leads to the ether (3). Oxidation of that product withchromium trioxide then leads to the substitutedsuccinic anhydride (4). Treatment of anhydride withpolyphosphoric acid leads totheacylation of the aromatic ring and the formation of thebenzopyranone ring (5). Theketone is then selectively reduced by any of several methods, as, for example, conversion to adithiolane followed byMozingo reduction to6. Thecarboxylic acid is next reduced to the correspondingaldehyde (7) by successive conversion to anacid chloride followed byhydrogenation in the presence ofthiophene. A secondhydrogenation in the presence ofbenzylamine leads to thereductive amination product (8).Michael addition of the amino group in8 toacrylonitrile leads to a1,4-addition and the formation of (9). Reduction of thenitrile affords thediamine (10). Reaction of this last diamine withtetrahydropyrimidine chloride (11), itself formed by treatment oftrimethylene urea withphosphorus oxychloride, leads to the displacement of halogen by the terminal, and thus more accessible, amino group in (10). There is thus formed the serotonergic agent alniditan (12).

References

[edit]
  1. ^Leysen JE, Gommeren W, Heylen L, Luyten WH, Van de Weyer I, Vanhoenacker P, et al. (December 1996). "Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan".Molecular Pharmacology.50 (6):1567–1580.doi:10.1016/S0026-895X(25)09616-6.PMID 8967979.
  2. ^Van Lommen G, De Bruyn M, Schroven M, Verschueren W, Janssens W, Verrelst J, Leysen J (1995). "The discovery of a series of new non-indole 5HT1D agonists".Bioorganic & Medicinal Chemistry Letters.5 (22):2649–2654.doi:10.1016/0960-894X(95)00473-7.
Analgesic/abortive
Serotonergics
Ergolines
5-HT1 agonists
Triptans
Ditans
Others
CGRP-R antagonists
Others
Prophylactic
Calcium channel blockers
Progestogens
Sympatholytics
Tricyclic antidepressants
Anticonvulsants
Anti-CGRP/CGRP-RmAbs
CGRP-R antagonists
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7


Stub icon

Thisanalgesic-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Alniditan&oldid=1280968165"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp